Lloyd Advisory Services’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
CI
APM
HIIFS
Lloyd Advisory Services's XBI Position: Q2 2022 in Review
Lloyd Advisory Services sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2022, closing a stake of 80 shares — an estimated $7K sold.
Lloyd Advisory Services first reported a position in XBI in Q4 2021 and held it in 2 quarters. The position peaked at $9K in Q4 2021. 706 funds tracked by Wall St. Rank hold XBI as of Q2 2022.
- Lloyd Advisory Services reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2022 after selling out during the quarter.
- Lloyd Advisory Services sold 80 State Street SPDR S&P Biotech ETF shares in Q2 2022, an estimated $7K.
- Lloyd Advisory Services first reported a position in State Street SPDR S&P Biotech ETF in Q4 2021 and held it in 2 quarters.
- Lloyd Advisory Services's State Street SPDR S&P Biotech ETF position peaked at $9K in Q4 2021.
- 706 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2022.
Based on Lloyd Advisory Services's 13F filing for Q2 2022, filed 15 Aug 2022.